Titel

Merkliste
1 Ergebnisse

Discovery and Optimization of Pyrazole Amides as Inhibitors..:

Jon H. Come (5395523) ; Timothy J. Senter (1309548) ; Michael P. Clark (1764619)...
https://figshare.com/articles/dataset/Discovery_and_Optimization_of_Pyrazole_Amides_as_Inhibitors_of_ELOVL1/16958668. , 2021

Link: https://doi.org/10.1021/acs.jmedchem.1c00944.s002

RT Journal
T1 <Title>Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16958668&Exemplar=1&LAN=DE
				
A1 Jon H. Come (5395523)
A1 Timothy J. Senter (1309548)
A1 Michael P. Clark (1764619)
A1 John J. Court (1764601)
A1 Zachary Gale-Day (11663926)
A1 Wenxin Gu (1764613)
A1 Elaine Krueger (1720042)
A1 Jianglin Liang (1764637)
A1 Mark Morris (1834648)
A1 Suganthini Nanthakumar (2342815)
A1 Hardwin O'Dowd (1570984)
A1 Francois Maltais (2342827)
A1 Ganesh Iyer (2481568)
A1 John Andreassi (11663929)
A1 Christina Boucher (1562233)
A1 Tony Considine (11663932)
A1 Cameron S. Moody (1562266)
A1 William Taylor (373883)
A1 Arun K. Mohanty (11663935)
A1 Yulin Huang (447676)
A1 Harmon Zuccola (1816819)
A1 Joyce Coll (2884850)
A1 Kenneth C. Bonanno (2884844)
A1 Kevin J. Gagnon (1330194)
A1 Lu Gan (33435)
A1 Fan Lu (490738)
A1 Hong Gao (68166)
A1 Ananthisrinivas Chakilam (11663938)
A1 Juntyma Engtrakul (11663941)
A1 Bin Song (446187)
A1 Dan Crawford (8315991)
A1 Elisabeth Doyle (1900438)
A1 Tal Kramer (11663944)
A1 Bryan Vought (11663947)
A1 Jonathan Phillips (6332132)
A1 Raymond Kemper (11663950)
A1 Martin Sanders (11663953)
A1 Rebecca Swett (149249)
A1 Brinley Furey (11663956)
A1 Ray Winquist (11663959)
A1 Mark E. Bunnage (1290480)
A1 Katrina L. Jackson (2047516)
A1 Paul S. Charifson (1720039)
A1 Sanjay S. Magavi (11663962)
YR 2021
K1 Biochemistry
K1 Medicine
K1 Neuroscience
K1 Pharmacology
K1 Chemical Sciences not elsewhere classified
K1 cns precluded progression
K1 central nervous system
K1 0 vlcfa synthesis
K1 0 vlcfa concentrations
K1 treatment reduced c26
K1 preclinical safety findings
K1 selectively inhibits elovl1
K1 ald patient fibroblasts
K1 27 </ b
K1 vivo </
K1 reducing c26
K1 findings require
K1 elovl1 accumulation
K1 elovl1 )
K1 type levels
K1 thiazole amides
K1 relevant tissue
K1 pyrazole amides
K1 pathologies observed
K1 highly potent
K1 effective approach
K1 ald )
JF https://figshare.com/articles/dataset/Discovery_and_Optimization_of_Pyrazole_Amides_as_Inhibitors_of_ELOVL1/16958668
LK http://dx.doi.org/https://doi.org/10.1021/acs.jmedchem.1c00944.s002
DO https://doi.org/10.1021/acs.jmedchem.1c00944.s002
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)